Cargando…
Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495079/ https://www.ncbi.nlm.nih.gov/pubmed/28717352 http://dx.doi.org/10.3389/fneur.2017.00311 |
| _version_ | 1783247759676014592 |
|---|---|
| author | New, Pamela Zyman Rosenfeld, Myrna Rachel |
| author_facet | New, Pamela Zyman Rosenfeld, Myrna Rachel |
| author_sort | New, Pamela Zyman |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5495079 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54950792017-07-17 Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response New, Pamela Zyman Rosenfeld, Myrna Rachel Front Neurol Neuroscience Frontiers Media S.A. 2017-07-03 /pmc/articles/PMC5495079/ /pubmed/28717352 http://dx.doi.org/10.3389/fneur.2017.00311 Text en Copyright © 2017 New and Rosenfeld. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neuroscience New, Pamela Zyman Rosenfeld, Myrna Rachel Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response |
| title | Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response |
| title_full | Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response |
| title_fullStr | Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response |
| title_full_unstemmed | Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response |
| title_short | Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response |
| title_sort | editorial: pitfalls in the neuro-imaging of glioblastoma in the era of antiangiogenic and immune-targeted therapy—detecting elusive disease, defining response |
| topic | Neuroscience |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495079/ https://www.ncbi.nlm.nih.gov/pubmed/28717352 http://dx.doi.org/10.3389/fneur.2017.00311 |
| work_keys_str_mv | AT newpamelazyman editorialpitfallsintheneuroimagingofglioblastomaintheeraofantiangiogenicandimmunetargetedtherapydetectingelusivediseasedefiningresponse AT rosenfeldmyrnarachel editorialpitfallsintheneuroimagingofglioblastomaintheeraofantiangiogenicandimmunetargetedtherapydetectingelusivediseasedefiningresponse |